News Posted on August 10, 2023 HIV cell therapy biotech Addimmune to go public via SPAC merger … – Endpoints News HIV cell therapy biotech Addimmune to go public via SPAC merger … Endpoints News Source: HIV cell therapy biotech Addimmune to go public via SPAC merger … – Endpoints News By sf-admin